Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-22-003399
Filing Date
2022-06-22
Accepted
2022-06-22 16:31:29
Documents
1
Period of Report
2022-06-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 4049
  Complete submission text file 0001179110-22-003399.txt   5649
Mailing Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080 415-798-8589
Tempest Therapeutics, Inc. (Issuer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ADURO BIOTECH, INC. 740 HEINZ AVENUE BERKELEY CA 94710
Business Address
Dubensky Thomas W. (Reporting) CIK: 0001635590 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35890 | Film No.: 221032427